![]() Abeona Therapeutics Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome. | ||
Founding Date | Founding Date 1904 | Founding Date 2013 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Dallas, US HQ Madrid, ES Cleveland, US New York, US |
Employees | Employees 7,5692% decrease | Employees 5737% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $5.8m (FY, 2025) |
Gross profit | Gross profit $4.5b (FY, 2020) | Gross profit $4.3m (FY, 2025) |

Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome.
View company